Theresa L Whiteside Selected Research

Pathologic Complete Response

8/2020	Increased small extracellular vesicle secretion after chemotherapy via upregulation of cholesterol metabolism in acute myeloid leukaemia.
5/2009	Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Theresa L Whiteside Research Topics

Disease

178	Neoplasms (Cancer) 01/2024 - 02/2002
53	Squamous Cell Carcinoma of Head and Neck 11/2023 - 06/2002
27	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 04/2002
21	Melanoma (Melanoma, Malignant) 01/2024 - 07/2002
10	Disease Progression 01/2023 - 06/2008
9	Glioma (Gliomas) 01/2022 - 08/2003
9	Carcinoma (Carcinomatosis) 01/2018 - 12/2002
8	Leukemia 12/2023 - 01/2015
8	Neoplasm Metastasis (Metastasis) 01/2019 - 02/2003
7	Carcinogenesis 01/2023 - 03/2005
7	Breast Neoplasms (Breast Cancer) 07/2021 - 01/2003
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 01/2010
6	Inflammation (Inflammations) 01/2022 - 01/2007
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2013 - 01/2005
5	Infections 12/2015 - 10/2004
5	Ovarian Neoplasms (Ovarian Cancer) 03/2012 - 08/2003
4	Human Influenza (Influenza) 08/2012 - 06/2002
3	Lymphatic Metastasis 06/2020 - 05/2006
3	Glioblastoma (Glioblastoma Multiforme) 06/2020 - 08/2003
2	Lung Neoplasms (Lung Cancer) 10/2020 - 03/2003
2	Pathologic Complete Response 08/2020 - 05/2009
2	Lymphoma (Lymphomas) 01/2020 - 04/2016
2	Viremia 05/2016 - 02/2008
2	Residual Neoplasm 01/2016 - 11/2007
2	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 01/2013
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 06/2012 - 06/2012

Drug/Important Bio-Agent (IBA)

39	Proteins (Proteins, Gene)FDA Link 11/2023 - 02/2002
36	Biomarkers (Surrogate Marker)IBA 12/2023 - 02/2003
32	AntigensIBA 12/2023 - 03/2002
31	Peptides (Polypeptides)IBA 09/2017 - 02/2002
26	CytokinesIBA 01/2018 - 02/2003
26	VaccinesIBA 05/2016 - 07/2002
23	EpitopesIBA 07/2019 - 02/2002
15	Adenosine (Adenocard)FDA LinkGeneric 01/2024 - 10/2009
9	LigandsIBA 12/2019 - 02/2002
9	Interleukin-2 (IL2)IBA 12/2011 - 07/2002
8	MicroRNAs (MicroRNA)IBA 05/2023 - 04/2016
8	Cancer VaccinesIBA 01/2016 - 02/2002
6	Adenosine Triphosphate (ATP)IBA 01/2024 - 09/2010
6	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2024 - 01/2013
6	Tumor Biomarkers (Tumor Markers)IBA 05/2023 - 11/2009
6	AntibodiesIBA 01/2021 - 09/2009
6	Messenger RNA (mRNA)IBA 11/2020 - 03/2004
6	IRX 2IBA 01/2018 - 04/2011
6	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2017 - 04/2009
6	EnzymesIBA 01/2017 - 02/2003
6	Interleukin-10 (Interleukin 10)IBA 04/2016 - 09/2007
6	Neoplasm Antigens (Tumor Antigens)IBA 05/2014 - 10/2004
6	Interleukin-15 (Interleukin 15)IBA 09/2011 - 09/2005
6	Fas Ligand Protein (Fas Ligand)IBA 09/2009 - 02/2002
5	Nucleic AcidsIBA 01/2021 - 01/2015
5	Protein Subunit VaccinesIBA 07/2019 - 03/2012
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 04/2005
4	Monoclonal AntibodiesIBA 12/2023 - 07/2009
4	4-Nitroquinoline-1-oxide (4 Nitroquinoline 1 oxide)IBA 01/2023 - 11/2018
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 05/2006
4	Small Interfering RNA (siRNA)IBA 11/2019 - 09/2007
4	InterferonsIBA 01/2019 - 09/2002
4	gallium arsenide (GaAs)IBA 12/2016 - 12/2007
4	DNA (Deoxyribonucleic Acid)IBA 04/2016 - 07/2002
4	Annexin A5IBA 12/2012 - 01/2003
4	Prostaglandins EIBA 02/2012 - 09/2007
4	HLA-A*02:01 antigenIBA 11/2007 - 10/2004
4	Histocompatibility Antigens Class IIBA 07/2006 - 11/2003
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2006 - 12/2002
3	Muromonab-CD3 (Muromonab CD3)FDA Link 12/2011 - 02/2009
3	Interleukin-5 (Interleukin 5)IBA 09/2009 - 03/2002
3	HLA-DR Antigens (HLA-DR)IBA 09/2008 - 02/2006
3	HLA-A Antigens (HLA-A)IBA 10/2007 - 12/2005
2	TetraspaninsIBA 12/2023 - 01/2021
2	Death Domain ReceptorsIBA 01/2023 - 02/2002
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2022 - 09/2011
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 07/2012
2	ProteomeIBA 01/2021 - 01/2019
2	Cetuximab (Erbitux)FDA Link 01/2019 - 06/2015
2	poly ICLCIBA 01/2016 - 01/2011
2	Interleukin-8 (Interleukin 8)IBA 06/2015 - 04/2009
2	Lysine (L-Lysine)FDA Link 07/2014 - 01/2011
2	Poly I-CIBA 07/2014 - 01/2011
2	Carboxymethylcellulose Sodium (Polycell)FDA Link 07/2014 - 01/2011
2	Dinoprostone (PGE2)FDA Link 01/2014 - 01/2013
2	Protein Isoforms (Isoforms)IBA 12/2012 - 10/2011
2	LipopolysaccharidesIBA 12/2011 - 04/2009
2	ErbB Receptors (EGF Receptor)IBA 10/2011 - 06/2009
2	ProstaglandinsIBA 09/2011 - 09/2007
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 09/2011 - 09/2007
2	ChemokinesIBA 06/2009 - 05/2006
2	InterleukinsIBA 04/2009 - 12/2007
2	NF-kappa B (NF-kB)IBA 04/2009 - 01/2007
2	Interleukin-4 (Interleukin 4)IBA 12/2007 - 08/2003
2	Sirolimus (Rapamycin)FDA Link 12/2007 - 09/2007
2	Chemokine ReceptorsIBA 05/2006 - 03/2004

Therapy/Procedure

76	Therapeutics 12/2023 - 04/2002
36	Immunotherapy 01/2022 - 06/2002
9	Drug Therapy (Chemotherapy) 12/2023 - 08/2004
5	Radiotherapy 01/2019 - 12/2004
4	Biological Therapy 05/2011 - 12/2002
2	Art Therapy 05/2016 - 02/2008
2	Chemoprevention 02/2013 - 11/2007
2	Ligation 04/2009 - 10/2003